
    
      A phase 2 trial evaluating the safety and efficacy of once daily use of LEO 80185 gel
      containing calcipotriol 50 mcg/g plus betamethasone 0.5mg/g (as dipropionate) in adolescent
      subjects (aged 12 to 16 years, 11 months) with scalp and body psoriasis.
    
  